143 related articles for article (PubMed ID: 2819921)
1. The effects of some polyamines on putative behavioural indices of mesolimbic versus striatal dopaminergic function.
Hirsch SR; Richardson-Andrews R; Costall B; Kelly ME; de Belleroche J; Naylor RJ
Psychopharmacology (Berl); 1987; 93(1):101-4. PubMed ID: 2819921
[TBL] [Abstract][Full Text] [Related]
2. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
Koob GF; Simon H; Herman JP; Le Moal M
Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
[TBL] [Abstract][Full Text] [Related]
3. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
Costall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
[TBL] [Abstract][Full Text] [Related]
4. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
Costall B; Domeney AM; Naylor RJ; Tyers MB
Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
[TBL] [Abstract][Full Text] [Related]
5. The interaction of clonidine with dopamine-dependent behaviour in rodents.
Pycock CJ; Jenner PG; Marsden CD
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
[TBL] [Abstract][Full Text] [Related]
6. R-(+)-HA-966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine.
Hutson PH; Bristow LJ; Thorn L; Tricklebank MD
Br J Pharmacol; 1991 Aug; 103(4):2037-44. PubMed ID: 1655150
[TBL] [Abstract][Full Text] [Related]
7. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
Ford AP; Marsden CA
Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
[TBL] [Abstract][Full Text] [Related]
8. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
Broderick PA; Gardner EL; van Praag HM
Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
[TBL] [Abstract][Full Text] [Related]
9. Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.
Costall B; Domeney AM; Naylor RJ
Neuropharmacology; 1982 Apr; 21(4):327-35. PubMed ID: 7201088
[No Abstract] [Full Text] [Related]
10. Dopamine neurons grafted unilaterally to the nucleus accumbens affect drug-induced circling and locomotion.
Brundin P; Strecker RE; Londos E; Björklund A
Exp Brain Res; 1987; 69(1):183-94. PubMed ID: 3125059
[TBL] [Abstract][Full Text] [Related]
11. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat.
Kalivas PW; Duffy P
Biol Psychiatry; 1989 Apr; 25(7):913-28. PubMed ID: 2541803
[TBL] [Abstract][Full Text] [Related]
12. Chronic haloperidol-amphetamine interactions and mesolimbic dopamine.
Lynch MR; Kuhn HG; Carey RJ
Neuropsychobiology; 1988; 19(2):97-103. PubMed ID: 3226530
[TBL] [Abstract][Full Text] [Related]
13. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):205-18. PubMed ID: 3762735
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
Costall B; Eniojukan JF; Naylor RJ
Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
[TBL] [Abstract][Full Text] [Related]
15. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
Costall B; Eniojukan JF; Naylor RJ
Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
[TBL] [Abstract][Full Text] [Related]
16. Dopamine characteristics in rat genotypes with distinct susceptibility to epileptic activity: apomorphine-induced stereotyped gnawing and novelty/amphetamine-induced locomotor stimulation.
de Bruin NM; van Luijtelaar EL; Cools AR; Ellenbroek BA
Behav Pharmacol; 2001 Nov; 12(6-7):517-25. PubMed ID: 11742146
[TBL] [Abstract][Full Text] [Related]
17. Evidence that apomorphine and (+)-amphetamine produce different types of circling in rats.
Cools AR; Scheenen W; Eilam D; Golani I
Behav Brain Res; 1989 Aug; 34(1-2):111-6. PubMed ID: 2765168
[TBL] [Abstract][Full Text] [Related]
18. Modulation of CNS dopamine receptors by peptides.
Mishra RK
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):437-42. PubMed ID: 6141599
[TBL] [Abstract][Full Text] [Related]
19. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
Costall B; Holmes SW; Kelly ME; Naylor RJ
Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
[TBL] [Abstract][Full Text] [Related]
20. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis.
Sharp T; Zetterström T; Ljungberg T; Ungerstedt U
Brain Res; 1987 Jan; 401(2):322-30. PubMed ID: 3815099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
